Multiple Myeloma - Krafts & Johns Flashcards
What is the typical clinical presentation of mulitiple myeloma?
- Bone pain (80%)
- lytic bone lesions
- hypercalcemia
- Bruising or bleeding (low platelet count)
- Infections
- Renal failure (50% - plugged glomeruli)
- Hyperviscosity Syndrome
What is the classic triad of symptoms for Multiple Myeloma?
- Anemia
- Bone pain
- Renal failure
What causes Hyperviscosity Syndrome (purpura, confusion, decreased vision)?
- non-differentiated Plasmablasts produce large amounts of immunoglobulins (IgG, IgA)
- normal cell death of plasma cells by apoptosis doesn’t occur
What are the three key pathology features of Multiple Myeloma?
- Monoclonal proliferation of plasma cells
- Monoclonal gammopathy
- Decreased levels of other, normal (polyclonal) immunoglobulins.
What are typical lab findings in Multiple Myeloma?
- big monoclonal gammopathy in the blood, or urine, or both
- M-spike
- due to big quantity of monoclonal immunoglobulin
- Type of IgG
- IgG (60%)
- IgA (20%)
- Bence-Jones protein in urine
- malignant plasma cells secrete only light chains → filtered out by kidney
- Decreased normal Ig
- cancer cells inhibiting normal plasma cell functioning
What blood morphologies are seen in Multiple Myeloma?
- Anemia
- Rouleaux (stacked RBCs)
- rarely see Plasma cells
What bone marrow morphologies are seen in Multiple Myeloma?
- Plasma cells
- <20% (normal 3%)
- varied stages of maturity
- Russell bodies (small, reddish cytoplasmic blobs containing immunoglobulin)
- Dutcher bodies (large, single, intranuclear pseudoinclusions that look like holes and contain immunoglobulin)
- Flame cells
- Amyloid
- due to over-production of immunoglobulin light chains
How come you see rouleaux in myeloma?
- abundant amounts of immunoglobulin in the blood disrupts the normal repellant force between RBCs
- Ig breaks the “zeta potential”
What are some of the other plasma cell disorders?
- Solitary plasmacytoma
- localized myeloma (one part of body)
- Plasma cell leukemia
- presents de novo OR end result of MM
- Waldenström Macroglobulinemia
- Lymphoplasmacytoid lymphoma
- overproduces IgM
- Hyperviscosity syndrome (retina)
- MGUS (Monoclonal gammopathy of undetermined significance)
- small M-spike with no myeloma symptoms (not malignant)
- occasionally transforms into myeloma (monitor condition)
What are the three laboratory tests used to judge the severity of Multiple Myeloma as treatment progresses?
- Serum protein electrophoresis
- Serum immunoelectrophoresis
- Urine immunoelectrophoresis
What is the treatment for Multiple Myeloma?
- Chemotherapy
- Dexamethasone (steroid)
- Melphalan (alkylating agent)
- Cyclophosphamide (alkylating agent)
- Autologous Peripheral Blood Stem Cell Transplant (x2)
- Bone Marrow Transplant
- New Treatments: Thalidomide, Lenalidomide, Bortezomib
What is the prognosis for patients with Multiple Myeloma?
- Prognosis without bone marrow transplantation is poor (median survival = 3 years).
- Conventional chemotherapy = 3-4 years
What are the specific (underlying) causes of death in Multiple Myeloma?
- Pancytopenia post bone marrow transplant
- Renal failure
- Sepsis
- Acute leukemia